Cboe Global Markets, Inc. CBOE

Founded in 1973, Cboe controls the largest option exchange in the US, which provides around 60% of the firm's revenue. The company is best known for its proprietary S&P 500 and VIX index options, which it offers through an exclusive contract with S&P Global. The firm moved into US and European equities through the $3.4 billion acquisition of BATS in 2017. Cboe has continued to look to expand internationally, using acquisitions to build a presence in both Canada and Australia.

Con 4 acciones de CBOE (USD 1.113,02) habrías recibido USD 12,08 en dividendos en los últimos 12 meses.

• Zacks Investment Research 5 oct

  Cboe Global Secures 25-Year SPX Rights: Can Volume Boost Growth?

  Cboe Global Markets has extended its exclusive licensing agreement with S&P Dow Jones Indices for SPX options through 2051. SPX options recorded record volume of 970.6 million contracts in 2025 with 25% year-over-year daily volume growth. While the extension supports long-term revenue growth and product innovation, revised royalty terms beginning in 2027 could increase costs. Competitors CME Group and Nasdaq continue expanding their own index derivatives offerings.

  

• Zacks Investment Research 1 oct

  Cboe Global Market's New KPI Contracts Could Open a New Growth Avenue

  Cboe Global Markets plans to launch binary contracts tied to company-specific key performance indicators (KPIs) in October 2026, pending regulatory approval. The products will initially be linked to 23 U.S.-listed companies and will be offered through Robinhood as the first retail broker. CBOE Clear U.S. is seeking SEC registration to clear these contracts, potentially expanding CBOE's clearing business and retail reach.

  

• Zacks Investment Research 30 sept

  CBOE (CBOE) Surges 3.4%: Is This an Indication of Further Gains?

  CBOE Global (CBOE) shares rose 3.4% to close at $261.75 on solid volume, though the stock is down 15.6% over the past four weeks. The company expects quarterly earnings of $3.40 per share (+27.3% YoY) and revenues of $697.52 million (+15.2% YoY). However, consensus EPS estimates have remained unchanged over the last 30 days, which may limit further upside momentum. CBOE carries a Zacks Rank #3 (Hold) rating.

  

• The Motley Fool 16 sept

  CME vs. Morningstar: Which Financial Stock Is a Better Buy in 2026?

  CME Group and Morningstar are compared as financial infrastructure plays. CME dominates derivatives trading with an impressive 62% net margin and $6.5B revenue, but trades at a premium valuation (forward P/E 22.5). Morningstar offers investment research with lower margins (15.3%) but more attractive valuation (forward P/E 15.5). The author leans toward CME despite valuation concerns due to its superior profitability and dividend, though both stocks have underperformed the S&P 500 over longer periods.

  

• Zacks Investment Research 7 sept

  NDAQ Boosts AI and Data-Driven Investment Technology With Dasseti

  Nasdaq has completed its acquisition of Dasseti, an AI-powered due diligence and monitoring platform, expanding its institutional investment-technology capabilities. The deal integrates Dasseti into eVestment and provides access to an ecosystem of 17,000 asset managers representing $34 trillion in AUM, supporting Nasdaq's shift toward higher-value data, analytics, and workflow technology.